Position in REGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$341,158,687
+$73,164,640 QoQ
Shares Held
547,132
+57.7% QoQ
Ownership
0.531%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#30
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. REGN ranks #1 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
547,132 | $341,158,687 | |
| 2 | INCY |
Incyte Corp
|
1,587,996 | $180,015,226 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
1,829,545 | $159,078,937 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,179 | $143,643,884 | |
| 5 | EXEL |
Exelixis, Inc.
|
2,543,353 | $138,383,836 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
421,534 | $126,894,380 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
324,900 | $120,755,583 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
482,061 | $117,994,070 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $341,158,687 | 547,132 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $267,994,047 | 346,855 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $158,798,358 | 205,732 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $111,473,963 | 198,257 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $96,623,100 | 184,044 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $72,251,481 | 113,920 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $194,175,459 | 272,592 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $306,900,055 | 291,941 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $380,793,423 | 362,305 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $323,850,935 | 336,472 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $321,410,225 | 365,950 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $139,942,702 | 170,048 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $116,128,997 | 161,618 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $183,787,037 | 223,675 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $144,067,123 | 199,680 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $312,255,815 | 453,287 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $235,607,275 | 398,571 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $120,739,357 | 172,875 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $128,632,414 | 203,687 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $119,654,979 | 197,718 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $96,208,515 | 172,250 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $82,353,328 | 174,057 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $78,225,654 | 161,921 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $203,839,408 | 364,142 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $223,928,392 | 359,061 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $122,203,850 | 250,269 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||